Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology
|
Buy Now
Peritoneal Carcinomatosis: Drugs and Diseases (Hardcover, 1996 ed.)
Loot Price: R5,496
Discovery Miles 54 960
|
|
Peritoneal Carcinomatosis: Drugs and Diseases (Hardcover, 1996 ed.)
Series: Cancer Treatment and Research, 81
Expected to ship within 10 - 15 working days
|
Peritoneal carcinomatosis dominates the clinical picture of many
patients with gastrointestinal, gynecological and urological
cancers. For many of them its dev astating effects contribute
directly to their death. Most clinicians consider peritoneal
carcinomatosis an incurable metastatic disease and give palliative
treatment, re stricted to limited surgery and systemic
chemotherapy. Contrary to this view, Paul Sugarbaker and his
collegues base their approach on the concept that peritoneal
carcinomatosis represents regional tumor spread, similar in its
impact on treatment and prognosis to that of lymph node metastases
in other malignancies. This concept emphasises the value of
regional tumor control, as a potentially curative measure. In this
book the combination of aggressive cytoreduction and
intraperitoneal chemotherapy to control peritoneal carcinomatosis
is extensively explored. Basic to this approach is the observation
that most cancer cells show only relative resistence against
commonly available drugs, which can be overcome by a sufficient
increase of drug concentrations in tumor tissue. After
intraperitoneal delivery, drugs will reach high tissue
concentrations in the superficial few cell layers, while plasma
concentrations will remain below toxic levels. Patients with only
limited residual tumor at the peritoneal surface after
cytoreduction may therefore benefit from intraperitoneal
chemotherapy.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.